IE50141B1 - Process for the preparation of gastric acid neutralizing agents and gastric acid neutralizing agents - Google Patents

Process for the preparation of gastric acid neutralizing agents and gastric acid neutralizing agents

Info

Publication number
IE50141B1
IE50141B1 IE1402/80A IE140280A IE50141B1 IE 50141 B1 IE50141 B1 IE 50141B1 IE 1402/80 A IE1402/80 A IE 1402/80A IE 140280 A IE140280 A IE 140280A IE 50141 B1 IE50141 B1 IE 50141B1
Authority
IE
Ireland
Prior art keywords
suspension
gastric acid
weight
hydrogenated
process according
Prior art date
Application number
IE1402/80A
Other languages
English (en)
Other versions
IE801402L (en
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of IE801402L publication Critical patent/IE801402L/xx
Publication of IE50141B1 publication Critical patent/IE50141B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IE1402/80A 1979-07-09 1980-07-07 Process for the preparation of gastric acid neutralizing agents and gastric acid neutralizing agents IE50141B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7905972A SE7905972L (sv) 1979-07-09 1979-07-09 Forfarande for framstellning av magsyraneutraliserande medel, magsyraneutraliserande medel, samt metod for behandling av hyperaciditet och dermed relaterande sjukdomstillstand

Publications (2)

Publication Number Publication Date
IE801402L IE801402L (en) 1981-01-09
IE50141B1 true IE50141B1 (en) 1986-02-19

Family

ID=20338481

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1402/80A IE50141B1 (en) 1979-07-09 1980-07-07 Process for the preparation of gastric acid neutralizing agents and gastric acid neutralizing agents

Country Status (21)

Country Link
US (1) US4465667A (ref)
EP (1) EP0022429B1 (ref)
JP (1) JPS5618922A (ref)
AR (1) AR228854A1 (ref)
AT (1) ATE1968T1 (ref)
AU (1) AU535403B2 (ref)
CA (1) CA1146860A (ref)
DE (1) DE3061333D1 (ref)
DK (1) DK154265C (ref)
ES (1) ES493187A0 (ref)
FI (1) FI71058C (ref)
GR (1) GR69623B (ref)
HK (1) HK43484A (ref)
IE (1) IE50141B1 (ref)
MY (1) MY8500445A (ref)
NO (1) NO152892C (ref)
NZ (1) NZ194165A (ref)
PH (2) PH16372A (ref)
PT (1) PT71503B (ref)
SE (1) SE7905972L (ref)
SG (1) SG9384G (ref)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0642001B2 (ja) * 1983-10-20 1994-06-01 セイコーエプソン株式会社 合成樹脂製レンズ
JPS6486101A (en) * 1987-06-18 1989-03-30 Toray Industries Production of antireflecting article
JPH0696536B2 (ja) * 1988-02-26 1994-11-30 佐藤製薬株式会社 制酸剤含有内用懸濁液
US5158770A (en) * 1989-12-29 1992-10-27 Freund Industrial Co., Ltd. Aqueous solution containing ginkgo leaf extract
AU657882B2 (en) * 1993-03-26 1995-03-23 Wallace Victor Wind Improvements in or relating to the treatment of diarrhoea
US5360793A (en) * 1993-05-24 1994-11-01 Sterling Winthrop Inc. Rafting antacid formulation
SE509300C2 (sv) * 1995-02-02 1999-01-11 Sueddeutsche Kalkstickstoff Katjoniskt dispergerade aluminiumhydroxiduppslamningar
US5569466A (en) * 1995-05-17 1996-10-29 R. P. Scherer Corporation Fill compositions for soft elastic gel capsules
US6187317B1 (en) 1999-07-14 2001-02-13 Judith Taylor Natural anti-diarrheal composition and method
EP1523984B1 (de) * 2003-10-13 2006-12-06 Salama, Zoser B. nat.rer.Dr. Pharmazeutische Zusammensetzung umfassend Oxoplatin und dessen Salze
US20060073202A1 (en) * 2004-10-05 2006-04-06 Rocca Jose G Dual component medicament delivery system

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2211745A (en) * 1940-04-18 1940-08-13 Alba Pharmaceutical Company In Compound of aluminum hydroxide and process of making the same
US2999790A (en) * 1959-08-24 1961-09-12 Sterling Drug Inc Stable aluminum hydroxide suspension
US3239416A (en) * 1963-05-29 1966-03-08 Armour Pharma Aluminum hydroxide-metal hydroxide antacid and process of making the same
US3272704A (en) * 1963-06-06 1966-09-13 Armour Pharma Stable aluminum hydroxide-magnesium compound codried gel antacids and process of making the same
US3499963A (en) * 1964-04-15 1970-03-10 Armour Pharma Codried aluminum hydroxide-aluminum chelate antacid
US3350266A (en) * 1964-06-04 1967-10-31 Bristol Myers Co Antacid composition comprising aluminum hydroxide, magnesium hydroxide and magnesium gluconate
IL32020A (en) * 1968-04-18 1972-11-28 Brown G Antacid compositions
US3599150A (en) * 1969-08-01 1971-08-10 Miles Lab Stabilized aluminum hydroxide suspensions
GB1414121A (en) * 1971-09-15 1975-11-19 Smith W J Antacid composition and its preparation
US3873694A (en) * 1973-09-27 1975-03-25 Cpc International Inc Direct compression tabletting composition and pharmaceutical tablets produced therefrom

Also Published As

Publication number Publication date
DK154265C (da) 1989-03-28
JPS5618922A (en) 1981-02-23
NO802030L (no) 1981-01-12
NO152892B (no) 1985-09-02
US4465667A (en) 1984-08-14
PT71503B (en) 1981-12-11
NO152892C (no) 1985-12-11
HK43484A (en) 1984-05-25
IE801402L (en) 1981-01-09
PT71503A (en) 1980-08-01
AU5973480A (en) 1981-01-15
DE3061333D1 (en) 1983-01-20
CA1146860A (en) 1983-05-24
PH16705A (en) 1984-01-20
EP0022429A1 (en) 1981-01-14
PH16372A (en) 1983-09-14
DK154265B (da) 1988-10-31
MY8500445A (en) 1985-12-31
ATE1968T1 (de) 1982-12-15
EP0022429B1 (en) 1982-12-15
JPS6411008B2 (ref) 1989-02-23
GR69623B (ref) 1982-07-06
AR228854A1 (es) 1983-04-29
ES8106835A1 (es) 1981-09-01
NZ194165A (en) 1984-07-06
DK290080A (da) 1981-01-10
SE7905972L (sv) 1981-01-10
FI71058C (fi) 1986-11-24
AU535403B2 (en) 1984-03-22
SG9384G (en) 1985-02-15
FI802139A7 (fi) 1981-01-10
FI71058B (fi) 1986-08-14
ES493187A0 (es) 1981-09-01

Similar Documents

Publication Publication Date Title
KR950002883B1 (ko) 발포성 커플의 제조방법
WO1993012779A1 (en) Compositions containing histamine-h2-receptor antagonists at low dosage
EP0022429B1 (en) Process for the preparation of gastric acid neutralizing agents and gastric acid neutralizing agents
KR0149029B1 (ko) 지사제 조성물
RU2126249C1 (ru) Фармацевтическая композиция для перорального введения для лечения патологического состояния верхних отделов желудочно-кишечного тракта
US3579634A (en) Novel antacid compositions and methods for their administration
JP2024525095A (ja) アルギネート、ポリリジン、及び種子防腐剤栄養製品並びに消化補助剤
US4704278A (en) Fluidized magaldrate suspension
CZ225893A3 (en) Chewing antacid preparation
CA2085873A1 (en) Treatment
US5661137A (en) Antacid pharmaceutical composition in the form of a suspension based on sucralfate gel
JP6641626B2 (ja) 制酸用医薬組成物
KR890000208B1 (ko) 마갈드레이트 조성물의 제조방법
JP2002509539A (ja) 制酸剤とパパインの組合せ物
US6110505A (en) Translucent antacid suspension containing co-dried dihydroxy aluminum sodium carbonate
CA1252045A (en) Fluidized magaldrate suspension
TR2022008098T2 (tr) Lantanyum karbonat oktahi̇drat i̇çeren kati oral farmasöti̇k kompozi̇syonlar
KR20120013285A (ko) 폴리스티렌설폰산금속염 함유 약학 조성물 및 이의 제조 방법
KR20100066731A (ko) 폴리스티렌설폰산금속염 함유 약학 조성물 및 이의 제조 방법